Clinical trial
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
NCT00111670 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00111670 |
|---|---|
| Title | A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes |
| Official title | A Randomized, Double-blind Study of the Effect of the DPP-IV Inhibitor on HbA1c and Safety in Patients With Type 2 Diabetes |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 2 |
| Intervention type | Drug |
| Interventions | DPP-IV Inhibitor, Placebo |
| Enrollment | 291 |
| Start date | Jun 1, 2005 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | May 25, 2005 |
| Last update posted | Nov 2, 2016 |
| Countries | Bulgaria, Costa Rica, Estonia, Latvia, Lithuania, Mexico, Puerto Rico, Romania, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: